pioglitazone hydrochloride

Key facts

INN

pioglitazone hydrochloride

Brand

PIOGLITAZONE HYDROCHLORIDE

Route

ORAL

Formulation

TABLET

Originator

TAKEDA PHARMACEUTICAL CO LTD

Related patents

patent

US 12385026

Stabilized alpha-galactosidase and uses thereof

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12268700

3-o-sulfo-galactosylceramide analogs as activators of type II NKT cells and uses

Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12194079

Therapeutic regimen for the treatment of Fabry using stabilized alpha-galactosid

Expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11396571

Polymers including galactose based blocks and uses thereof

Expires Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11116823

Treatment of α-galactosidase a deficiency

Expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10870842

Stabilized alpha-galactosidase and uses thereof

Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10744154

Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

Expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10280414

Stabilized α-galactosidase and uses thereof

Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is pioglitazone hydrochloride?

pioglitazone hydrochloride (PIOGLITAZONE HYDROCHLORIDE), is a pharmaceutical active ingredient, associated with TAKEDA PHARMACEUTICAL CO LTD, with approved status in the US.

What is the brand name for pioglitazone hydrochloride?

PIOGLITAZONE HYDROCHLORIDE is a marketed brand name for pioglitazone hydrochloride. Check FDA Drugs@FDA for the current US label holder.